This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rallied 6.2% to $6.04 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.1% to 16,724.46 and the Dow Jones Industrial Average rising 1.6% to 40,212.71.
This was the stock's sixth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 90.2% below its 52-week high of $61.90, which the company reached on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. rose 1.2% to $4.13, Fortress Biotech Inc. rose 3.5% to $1.46, and Viking Therapeutics Inc. rose 3.25% to $22.22.
Trading volume totaled 221,757, compared to the 50-day average of 250,078.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 11, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.